Company intelligence / Profile preview
Asgard Therapeutics
Lund, Skåne County, Swedenasgardthx.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Asgard Therapeutics has demonstrated strong preclinical proof-of-concept for its lead program AT-108, showing potent anti-tumor effects by converting tumor cells into dendritic cells within the body. This approach induces personalized immune responses and complete tumor regression in animal models. The company is preparing AT-108 for clinical trials, with CMC development underway and IND-enabling studies ongoing. First-in-human trials are anticipated following completion of these activities[2][6].
- Therapeutic areas
- Oncology
- Modalities
- Gene therapy (viral vector-based)In vivo cell reprogramming technologies[1][2][6][9]
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Exothera S.A. (process development & GMP manufacturing partner for viral vectors)[9]Johnson & Johnson Innovation – JJDC, Inc. (investor/partner)[2]RV Invest, Novo Holdings, Boehringer Ingelheim Venture Fund, Industrifonden (investors/partners)[2]
Beyond the preview
Go deeper on Asgard Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Asgard Therapeutics.